John Philip Jones - 09 Mar 2021 Form 4/A - Amendment Insider Report for ALIMERA SCIENCES INC

Role: Chief Financial Officer
Signature: John Phillip Jones
Issuer symbol: N/A
Transactions as of: 09 Mar 2021
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 06 Jan 2022, 15:52:24 UTC
Date Of Original Report: 10 Mar 2021
Next filing: 02 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ALIM	Common Stock						16,817	09 Mar 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On March 10, 2021, the reporting person filed a Form 4 that inadvertently added the 1,164 shares disposed on March 9, 2021 rather than subtracting such disposed shares in the calculation of the total amount of securities owned in Column 5. The amount in Column 5 of this amended report is the correct amount as of March 10, 2021. This omission has carried through the reporting person's subsequent calculations of the total amount of securities owned and reflected in Column 5 of subsequent Forms 4. As of the date of this amended report, before the filing of the Form 4 to be filed today to report the grants of stock options and shares of restricted stock to the reporting person, the reporting person beneficially owns 22,637 shares of the Issuer's Common Stock.

Content

On March 10, 2021, the reporting person filed a Form 4 that inadvertently added the 1,164 shares disposed on March 9, 2021 rather than subtracting such disposed shares in the calculation of the total amount of securities owned in Column 5. The amount in Column 5 of this amended report is the correct amount as of March 10, 2021. This omission has carried through the reporting person's subsequent calculations of the total amount of securities owned and reflected in Column 5 of subsequent Forms 4. As of the date of this amended report, before the filing of the Form 4 to be filed today to report the grants of stock options and shares of restricted stock to the reporting person, the reporting person beneficially owns 22,637 shares of the Issuer's Common Stock.